Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7BQU

Cereblon in complex with SALL4 and (S)-thalidomide

Summary for 7BQU
Entry DOI10.2210/pdb7bqu/pdb
DescriptorProtein cereblon, Sal-like protein 4, S-Thalidomide, ... (5 entities in total)
Functional Keywordszinc finger, e3 ubiquitin ligase, complex, thalidomide, metal binding protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight16134.24
Authors
Furihata, H.,Miyauchi, Y.,Asano, A.,Tanokura, M.,Miyakawa, T. (deposition date: 2020-03-25, release date: 2020-08-26, Last modification date: 2023-11-29)
Primary citationFurihata, H.,Yamanaka, S.,Honda, T.,Miyauchi, Y.,Asano, A.,Shibata, N.,Tanokura, M.,Sawasaki, T.,Miyakawa, T.
Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide.
Nat Commun, 11:4578-4578, 2020
Cited by
PubMed Abstract: Thalidomide and its derivatives exert not only therapeutic effects as immunomodulatory drugs (IMiDs) but also adverse effects such as teratogenicity, which are due in part to different C2H2 zinc-finger (ZF) transcription factors, IKZF1 (or IKZF3) and SALL4, respectively. Here, we report the structural bases for the SALL4-specific proteasomal degradation induced by 5-hydroxythalidomide, a primary thalidomide metabolite generated by the enzymatic activity of cytochrome P450 isozymes, through the interaction with cereblon (CRBN). The crystal structure of the metabolite-mediated human SALL4-CRBN complex and mutagenesis studies elucidate the complex formation enhanced by the interaction between CRBN and an additional hydroxy group of (S)-5-hydroxythalidomide and the variation in the second residue of β-hairpin structure that underlies the C2H2 ZF-type neo-morphic substrate (neosubstrate) selectivity of 5-hydroxythalidomide. These findings deepen our understanding of the pharmaceutical action of IMiDs and provide structural evidence that the glue-type E3 ligase modulators cause altered neosubstrate specificities through their metabolism.
PubMed: 32929090
DOI: 10.1038/s41467-020-18488-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

226707

数据于2024-10-30公开中

PDB statisticsPDBj update infoContact PDBjnumon